Erratum: Bimatoprost 0.01% vs bimatoprost 0.03%: a 12-month prospective trial of clinical and in vivo confocal microscopy in glaucoma patients

被引：0

作者：

M Figus

M Nardi

P Piaggi

M Sartini

G Guidi

L Martini

S Lazzeri

机构：

来源：

Eye | 2014年 / 28卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Correction to: Eye (2014) 28, 422–429; doi:10.1038/eye.2013.304; published online 17 January 2014 Since the publication of the above article, it has been noted that the colour of the lines in Figure 1 were the wrong way round. The correct figure appears below. The authors apologise for this error.

引用

页码：506 / 506

共 50 条

[1] Bimatoprost 0.01% vs bimatoprost 0.03%: a 12-month prospective trial of clinical and in vivo confocal microscopy in glaucoma patients (vol 28, pg 422, 2014)
Figus, M.
Nardi, M.
Piaggi, P.
Sartini, M.
Guidi, G.
Martini, L.
Lazzeri, S.
EYE, 2014, 28 (04) : 506 - 506
[2] A twelve-months, randomized, prospective, open-label, parallel-group of in vivo confocal microscopic findings in glaucoma patients treated with bimatoprost 0.01% or bimatoprost 0.03%
Figus, Michele
Lazzeri, Stefano
Posarelli, Chiara
Martini, Luca
Nardi, Marco
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
[3] Twelve-Month, Randomized, Controlled Trial of Bimatoprost 0.01%, 0.0125%, and 0.03% in Patients with Glaucoma or Ocular Hypertension
Katz, L. Jay
Cohen, John S.
Batoosingh, Amy L.
Felix, Carlos
Shu, Vincent
Schiffman, Rhett M.
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 149 (04) : 661 - 671
[4] Difference in intraocular pressure following involuntary switch from bimatoprost 0.03% to bimatoprost 0.01% in glaucoma patients
Moussa, Kareem
Chien, Jason L.
Porco, Travis
Stamper, Robert L.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
[5] Retrospective Analysis of Switching Bimatoprost 0.01% to Bimatoprost 0.03% in Patients with Various Types of Glaucoma and Ocular Hypertension
Xu, Kai Man
Cho, Ryan
Chan, Toby Yiu Bong
CLINICAL OPHTHALMOLOGY, 2022, 16 : 2385 - 2390
[6] Difference in intraocular pressure following involuntary switch from bimatoprost 0.03% to bimatoprost 0.01% in glaucoma patients
Nguyen, Kristy
Moussa, Kareem
Chien, Jason
Stamper, Robert L.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
[7] 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
E. Randy Craven
Thomas Walters
William C. Christie
Douglas G. Day
Richard A. Lewis
Margot L. Goodkin
Michelle Chen
Veronica Wangsadipura
Michael R. Robinson
Marina Bejanian
Drugs, 2020, 80 : 167 - 179
[8] 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Craven, E. Randy
Walters, Thomas
Christie, William C.
Day, Douglas G.
Lewis, Richard A.
Goodkin, Margot L.
Chen, Michelle
Wangsadipura, Veronica
Robinson, Michael R.
Bejanian, Marina
Aung, Tin
Beck, Allen D.
Branch, James D.
Christie, William C.
Coote, Michael
Crane, Charles J.
Craven, E. Randy
Crichton, Andrew
Day, Douglas G.
Day, Steven
Durcan, F. Jane
Evans, Richard M.
Flynn, William J.
Gagne, Sebastien
Goldberg, Damien F.
Greiner, Jack V.
Jeppsen, Paul
Jinapriya, Delan
Johnson, C. Starck
Kurtz, Shimon
Lewis, Richard A.
Mansberger, Steven L.
Martel, Joseph R.
Perera, Shamira A.
Rotberg, Michael H.
Saltzmann, Robert M.
Schenker, Howard I.
Tepedino, Michael E.
Yap-Veloso, Maria Imelda R.
Uy, Harvey S.
Walters, Thomas R.
DRUGS, 2020, 80 (02) : 167 - 179
[9] Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: two randomized 12-week trials
Myers, Jonathan S.
Vold, Steven
Zaman, Fiaz
Williams, Julia M.
Hollander, David A.
CLINICAL OPHTHALMOLOGY, 2014, 8 : 643 - 652
[10] Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 12-Month Interim Results From a Phase 1/2 Clinical Trial
Perera, Shamira
Lewis, Richard A.
Christie, William C.
Day, Douglas G.
Craven, E. R.
Bejanian, Marina
Lee, Susan S.
Goodkin, Margot L.
Zhang, Jane
Robinson, Michael R.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)

← 1 2 3 4 5 →